Pancreatic carcinoma

Pancreatic carcinoma is a malignant tumor arising from the cells of the pancreas in cats, representing one of the most serious forms of cancer affecting the feline digestive system. This aggressive cancer develops from the exocrine cells of the pancreas, which are responsible for producing digestive enzymes, distinguishing it from endocrine pancreatic tumors such as insulinomas that arise from hormone-producing cells. Pancreatic carcinoma is relatively uncommon in cats compared to some other species, but when it does occur, it typically follows an aggressive clinical course with early metastatic spread. The condition most frequently affects older cats, with the majority of diagnoses occurring in felines over ten years of age, though cats of any age can potentially be affected.

The development of pancreatic carcinoma involves the malignant transformation of normal pancreatic exocrine cells into cancerous cells that grow uncontrollably and invade surrounding tissues. The exact triggers for this transformation are not fully understood, but the cancer likely develops through a series of genetic mutations that accumulate over time, eventually leading to uncontrolled cellular proliferation. The pancreas sits in close proximity to vital structures including the liver, stomach, duodenum, and major blood vessels, which unfortunately facilitates early spread of the cancer to these neighboring organs and beyond.

The impact of pancreatic carcinoma on a cat's health is profound and typically severe. The tumor's location in the abdomen means it can interfere with normal digestive function, cause obstruction of the bile duct leading to jaundice, and spread to multiple organs relatively early in the disease course. Affected cats often experience significant weight loss, decreased appetite, vomiting, and general malaise. The aggressive nature of this cancer means that by the time clinical signs become apparent and the diagnosis is made, the disease has frequently already spread beyond the pancreas, making treatment challenging and significantly affecting prognosis.

Treatment options for pancreatic carcinoma in cats are limited, and the prognosis is generally guarded to poor. Surgical removal of the tumor is technically possible in some cases but is challenging due to the pancreas's location and blood supply, and is often not feasible when metastasis has already occurred. Early detection would theoretically improve outcomes, but the nonspecific nature of early symptoms and cats' tendency to hide illness means that diagnosis typically occurs at advanced stages. Veterinary care focuses on accurate diagnosis, staging to determine the extent of disease, and implementing appropriate treatment or palliative care strategies to maintain quality of life for as long as possible.

The primary causes of pancreatic carcinoma in cats involve the malignant transformation of normal pancreatic exocrine cells, though the specific triggers that initiate this process remain poorly understood. Cancer develops when the normal mechanisms controlling cell growth, division, and death become dysregulated, allowing cells to multiply uncontrollably and form tumors. In the case of pancreatic carcinoma, the acinar cells or ductal cells of the exocrine pancreas undergo this transformation, developing the ability to invade surrounding tissues and metastasize to distant sites. The rarity of this tumor type in cats has limited research into its specific causative factors.

Genetic and hereditary factors in feline pancreatic carcinoma have not been extensively studied, and no specific inherited mutations have been identified as causative. Unlike some human pancreatic cancers where specific genetic mutations have been well characterized, the molecular genetics of feline pancreatic carcinoma remain largely unexplored. There is no documented breed predisposition for this cancer, suggesting that inherited genetic factors may not play a major role, though individual genetic susceptibility cannot be ruled out. As with many cancers, a combination of genetic susceptibility and environmental or random factors likely contributes to tumor development.

Environmental and lifestyle factors that might contribute to pancreatic carcinoma development in cats are not well defined. Chronic inflammation of the pancreas, known as pancreatitis, has been suggested as a potential risk factor, as chronic inflammatory conditions in various organs can increase cancer risk over time. However, a direct causal relationship between pancreatitis and pancreatic carcinoma has not been established in cats. Dietary factors, exposure to carcinogens, and other environmental influences have not been specifically linked to feline pancreatic cancer, though the limited number of cases makes epidemiological studies challenging.

Age represents the most clearly identified risk factor for pancreatic carcinoma in cats. The majority of affected cats are senior felines, typically over ten years of age, with peak incidence occurring in cats between eleven and fifteen years old. This age association suggests that the accumulation of cellular damage and genetic mutations over a lifetime may contribute to cancer development. The longer a cat lives, the more opportunity exists for the multiple genetic alterations necessary for cancer development to accumulate. No sex predisposition has been consistently identified, with both male and female cats affected.

At the cellular and molecular level, pancreatic carcinoma develops through progressive genetic and epigenetic changes that alter normal cell function. Mutations affecting oncogenes, which promote cell growth, and tumor suppressor genes, which normally restrain cell division, can lead to uncontrolled proliferation. The tumor cells acquire the ability to invade through tissue barriers, enter blood and lymphatic vessels, and establish metastatic colonies in distant organs. The pancreatic tumor microenvironment, including interactions with surrounding stromal cells and immune cells, also influences tumor growth and spread. Understanding these mechanisms is important for developing new therapeutic approaches, though current treatment options for feline pancreatic carcinoma remain limited.

Early warning signs of pancreatic carcinoma in cats are often subtle and nonspecific, making early detection exceptionally challenging. Initial changes may include mild decreases in appetite, subtle weight loss, or slightly reduced activity levels that owners might attribute to normal aging. Because the pancreas is located deep within the abdomen and early tumors may not cause pain or obvious dysfunction, significant disease can be present before any noticeable symptoms develop. Cats are particularly adept at concealing signs of illness, which further delays recognition that something is wrong. By the time symptoms become apparent enough to prompt veterinary attention, the disease has often progressed substantially.

The most commonly observed symptoms of pancreatic carcinoma relate to digestive dysfunction and systemic effects of cancer. Decreased appetite progressing to anorexia is frequently reported, with affected cats showing diminishing interest in food over days to weeks. Weight loss is a hallmark feature, often becoming quite pronounced as the disease progresses. Vomiting is common and may be intermittent initially before becoming more frequent and severe. Some cats develop diarrhea or changes in stool consistency, while others may experience constipation. Abdominal discomfort, evidenced by reluctance to be handled around the belly, a hunched posture, or decreased activity, may be present.

Behavioral changes in cats with pancreatic carcinoma often reflect the discomfort and malaise associated with advanced cancer. Affected cats typically become less active, spending more time resting and showing reduced interest in play or interaction. Changes in sleeping patterns may occur, with cats seeking secluded spots to rest. Some cats become more vocal or irritable, potentially due to pain or discomfort. Decreased grooming leading to an unkempt coat is common in cats that do not feel well. Social cats may become withdrawn, while independent cats might seek more contact with their owners as they feel unwell.

Physical signs that owners or veterinarians may observe include visible weight loss with muscle wasting, particularly over the spine and hindquarters. Jaundice, characterized by yellowing of the skin, gums, and whites of the eyes, can develop when the tumor obstructs the bile duct, preventing normal bile flow. Abdominal distension may occur due to fluid accumulation secondary to tumor spread or if the tumor itself becomes large. Dehydration may be evident from tacky gums and skin tenting. In advanced cases, palpable abdominal masses may be detected during examination, though the deep location of the pancreas can make tumor detection by palpation difficult.

As the disease progresses, symptoms typically worsen and additional complications may develop. Severe weakness and lethargy become pronounced, with affected cats spending most of their time resting. Complete loss of appetite may occur, leading to rapid weight loss and muscle wasting. If the tumor has spread to the liver, signs of liver failure may develop, including more severe jaundice, clotting abnormalities, and accumulation of fluid in the abdomen. Metastasis to the lungs can cause breathing difficulties, while spread to other abdominal organs may cause additional gastrointestinal symptoms.

Emergency symptoms requiring immediate veterinary attention include collapse or extreme weakness, difficulty breathing, severe persistent vomiting preventing any intake, complete refusal to eat or drink for more than twenty-four hours, obvious severe abdominal pain with vocalization or inability to find a comfortable position, and sudden worsening of jaundice. Signs of internal bleeding, including pale gums, rapid breathing, and collapse, require immediate emergency care. Any sudden deterioration in a cat suspected of having or diagnosed with pancreatic carcinoma warrants urgent veterinary evaluation, as supportive care or pain management may need adjustment.

The diagnostic process for pancreatic carcinoma typically begins when a cat presents with nonspecific symptoms such as weight loss, decreased appetite, vomiting, or jaundice that prompt veterinary evaluation. During the initial examination, the veterinarian obtains a thorough history, including the duration and progression of symptoms, eating and drinking habits, and any other changes the owner has observed. Physical examination includes careful abdominal palpation, which may reveal masses, pain, or fluid accumulation, though small tumors deep in the abdomen may not be detectable by touch. Assessment of hydration status, body condition, and presence of jaundice provides important information about disease severity.

Diagnostic testing for suspected pancreatic carcinoma involves multiple approaches to visualize the tumor and assess overall health status. Blood work, including a complete blood count, serum chemistry panel, and pancreatic enzyme levels, provides information about organ function and may reveal abnormalities such as elevated liver enzymes, bilirubin elevation in cases with bile duct obstruction, anemia, or changes in white blood cell counts. Specific pancreatic tests such as feline pancreatic lipase immunoreactivity may be elevated but cannot distinguish between pancreatitis and cancer. Abdominal imaging is crucial for visualizing the tumor, with ultrasound being particularly valuable for evaluating the pancreas and detecting masses, changes in tissue architecture, and involvement of surrounding structures. Radiographs may show abdominal masses or fluid but provide less detail than ultrasound for pancreatic evaluation.

Differential diagnosis is essential because numerous conditions can cause similar symptoms. Pancreatitis, which involves inflammation of the pancreas without cancer, is much more common than pancreatic carcinoma and causes overlapping clinical signs. Inflammatory bowel disease, intestinal lymphoma, liver disease, and other gastrointestinal cancers must be considered. Cholangitis and cholangiohepatitis can cause jaundice similar to that seen with pancreatic tumors obstructing the bile duct. Other abdominal masses, including tumors of the spleen, liver, or intestines, may produce similar nonspecific symptoms. Accurate differentiation requires combining clinical findings, imaging results, and often tissue sampling.

Definitive diagnosis of pancreatic carcinoma requires histopathological examination of tumor tissue. This can be obtained through ultrasound-guided fine needle aspiration, which collects cells from the tumor for cytological evaluation, or through surgical biopsy, which provides a larger tissue sample for more detailed examination. Fine needle aspiration is less invasive but may not always yield a definitive diagnosis due to limited tissue sampling. Surgical exploration allows direct visualization of the tumor and surrounding organs, collection of adequate tissue for diagnosis, and potentially therapeutic tumor removal if the disease is localized. Staging tests to evaluate for metastatic spread, including thoracic radiographs to check the lungs and potentially CT scanning for comprehensive abdominal evaluation, help determine the extent of disease and guide treatment planning. The pathology results, combined with staging information, provide crucial information for prognosis and treatment decisions.

Emergency and immediate treatment for cats presenting with advanced pancreatic carcinoma or acute complications focuses on stabilization and supportive care. Cats that are severely debilitated, dehydrated, or in crisis require intravenous fluid therapy to restore hydration and support organ function. Anti-nausea medications help control vomiting, and pain management is essential for maintaining comfort. If bile duct obstruction has caused severe jaundice, interventions to relieve the obstruction may be considered. Nutritional support, potentially including appetite stimulants or assisted feeding, addresses the anorexia and weight loss common in affected cats. Stabilization may be necessary before any diagnostic procedures or treatment decisions can be made.

Surgical treatment represents the only potentially curative option for pancreatic carcinoma, but its applicability is limited. Surgical resection of pancreatic tumors is technically challenging due to the organ's location and its intimate relationship with major blood vessels and surrounding organs. Partial pancreatectomy, removing the affected portion of the pancreas along with the tumor, may be possible if the cancer is localized to one region of the pancreas and has not invaded surrounding structures or spread to distant sites. Unfortunately, by the time most pancreatic carcinomas are diagnosed, surgical resection is often not feasible due to local invasion or metastatic spread. When surgery is performed, careful postoperative monitoring for complications such as pancreatitis or diabetes mellitus is essential.

Medical management for pancreatic carcinoma is primarily supportive rather than curative. Pain management using appropriate analgesics is crucial for maintaining quality of life, with options including opioids, non-steroidal anti-inflammatory drugs when appropriate, and other pain medications. Anti-nausea medications help control vomiting and improve comfort. Appetite stimulants may encourage eating, and dietary management with highly palatable, easily digestible foods supports nutritional status. If the tumor has caused diabetes due to destruction of insulin-producing cells, insulin therapy may be required. Medications to support liver function may be helpful if bile duct obstruction or liver metastasis has affected hepatic function.

Chemotherapy has limited efficacy against pancreatic carcinoma in cats, and no standard chemotherapy protocols have been established for this tumor type. The aggressive biology of pancreatic carcinoma and its typical late presentation mean that chemotherapy, when attempted, rarely achieves significant tumor control. Some oncologists may offer chemotherapy protocols extrapolated from treatment of other tumor types, but expectations for response should be guarded. The potential benefits of chemotherapy must be weighed against the side effects and impact on quality of life, particularly in cats that are already debilitated from their disease.

Palliative care focuses on maintaining comfort and quality of life when curative treatment is not possible, which is the situation for most cats diagnosed with pancreatic carcinoma. Effective pain management is the cornerstone of palliative care, ensuring that cats remain comfortable during their remaining time. Nutritional support, even if it means offering whatever foods the cat will eat rather than an ideal diet, helps maintain strength and comfort. Environmental modifications to make rest and access to necessities easier support quality of life. Regular assessment of quality of life indicators helps guide ongoing care decisions and identifies when symptoms are no longer adequately controlled.

Treatment decisions for pancreatic carcinoma involve honest discussions between the veterinary team and the cat's family about realistic expectations. Given the typically poor prognosis associated with this cancer, owners must consider whether aggressive treatment attempts are appropriate or whether focusing on quality of life through palliative care better serves their cat's interests. Factors including the extent of disease, the cat's current condition, the family's ability to provide care, and financial considerations all influence treatment choices. The veterinary team can provide guidance about what each option entails and expected outcomes, but ultimately the family must make decisions that align with their values and their cat's best interests.

Recovery expectations following treatment for pancreatic carcinoma depend heavily on the treatment approach taken and the stage of disease at diagnosis. For the small number of cats that undergo successful surgical resection of a localized tumor, the immediate recovery period involves several days of hospitalization for monitoring and supportive care. Pain management, fluid therapy, and gradual reintroduction of oral feeding are components of postoperative care. The recovery timeline extends over several weeks, with activity restriction and careful monitoring during the initial two-week period while the surgical site heals. However, even with successful surgery, the risk of recurrence remains substantial given the aggressive nature of this cancer type.

Post-treatment care requirements vary based on the treatment provided. Cats recovering from surgery require regular monitoring of the surgical incision, administration of pain medications and any other prescribed drugs, and gradual return to normal activities. If diabetes has developed as a consequence of pancreatic tissue loss, ongoing insulin therapy and blood glucose monitoring become permanent care requirements. Cats receiving palliative care need consistent attention to comfort, with regular assessment and adjustment of medications to maintain quality of life. Regular veterinary follow-up appointments allow monitoring of disease status and adjustment of care plans as needed.

Prognosis for pancreatic carcinoma in cats is generally guarded to poor, reflecting the aggressive biology of this cancer and its typical late presentation. Even with treatment, survival times are often measured in weeks to months rather than years. Factors that influence prognosis include the extent of disease at diagnosis, whether surgical resection was possible and complete, and the cat's overall health status. Cats with localized disease that can be surgically removed have better prognoses than those with metastatic spread, though recurrence remains common. Response to any chemotherapy or supportive care also influences survival duration.

The long-term outlook for cats with pancreatic carcinoma must be approached with realistic expectations. Cure is rarely achieved, and management focuses on maintaining quality of life for whatever time remains. Regular monitoring through veterinary examinations and potentially imaging studies can track disease progression and guide adjustments to palliative care. Quality of life assessments should be performed regularly, considering factors such as appetite, comfort, mobility, and engagement with family. When symptoms can no longer be adequately controlled or quality of life deteriorates significantly, humane euthanasia may be the kindest option. Open communication between the veterinary team and the family throughout the course of disease helps ensure that care decisions align with the cat's best interests and the family's wishes.

Prevention of pancreatic carcinoma in cats is challenging because no specific modifiable risk factors have been identified for this disease. Unlike some cancers where clear causative factors such as viruses, toxins, or hereditary mutations can be addressed, the triggers for pancreatic carcinoma development remain unknown. This lack of understanding about causation means that targeted prevention strategies do not currently exist. However, general approaches to maintaining overall health may support pancreatic health and potentially reduce cancer risk, even if specific preventive effects cannot be proven.

Environmental health maintenance, while not specifically proven to prevent pancreatic cancer, supports overall wellbeing and may contribute to reduced disease risk generally. Minimizing exposure to potential environmental carcinogens, including secondhand smoke, household chemicals, and pesticides, is prudent general health advice. Maintaining a clean, low-stress living environment supports immune function and overall health. Reducing obesity through appropriate diet and encouraging activity may help, as obesity has been associated with increased cancer risk in various species, though specific links to feline pancreatic carcinoma have not been established.

Dietary considerations for pancreatic health include feeding a high-quality, nutritionally balanced diet appropriate for the cat's life stage. Avoiding excessive dietary fat may reduce pancreatic stress, as high-fat diets have been associated with pancreatitis in some animals. Maintaining a healthy body weight through appropriate caloric intake and avoiding overfeeding supports metabolic health. While no specific dietary factors have been proven to prevent pancreatic cancer, overall good nutrition supports immune function and cellular health. Some veterinarians recommend omega-3 fatty acid supplementation for general health benefits, though specific cancer-preventive effects are not established.

Regular veterinary care provides the best opportunity for early detection of pancreatic abnormalities, even if it cannot prevent cancer from developing. Annual or biannual wellness examinations for adult cats, and more frequent visits for senior cats, allow veterinarians to monitor for changes that might indicate developing problems. Blood work can reveal abnormalities in pancreatic enzymes or liver values that might prompt further investigation. Abdominal palpation during physical examination may detect masses, though early pancreatic tumors are often not palpable. Owners should promptly report concerning symptoms such as persistent weight loss, decreased appetite, or vomiting to their veterinarian.

Early intervention when abnormalities are detected offers the best chance for favorable outcomes. While prevention of pancreatic carcinoma may not be possible with current knowledge, early detection of pancreatic disease of any type allows for timely intervention. Prompt veterinary attention when symptoms develop increases the likelihood of diagnosis at earlier stages, when treatment options may be more feasible. For cats diagnosed with pancreatitis, appropriate management may help reduce chronic inflammation that could theoretically contribute to cancer risk over time. Research into the causes and prevention of feline pancreatic cancer continues, and future advances may provide more specific prevention strategies as understanding of this disease improves.

Daily management of a cat diagnosed with pancreatic carcinoma requires dedication to maintaining comfort and quality of life, particularly when cure is not achievable. Establishing a consistent daily routine provides stability and reduces stress for both the cat and caregivers. Medication administration must be reliable, with pain medications and anti-nausea drugs given on schedule to maintain consistent symptom control. Monitoring food and water intake daily helps track the cat's condition and identifies changes that might require veterinary attention. Keeping a simple daily log of observations, including appetite, activity level, vomiting episodes, and general demeanor, provides valuable information for veterinary consultations and helps track disease progression.

Creating an optimal home environment supports comfort for cats living with pancreatic carcinoma. A quiet, peaceful space away from household commotion allows for undisturbed rest. Soft, warm bedding in the cat's favorite locations provides physical comfort. Easy access to food, water, and litter boxes is essential, with low-sided boxes making access easier for cats with reduced mobility or abdominal discomfort. Multiple rest areas throughout accessible parts of the home allow the cat to choose where to spend time. Maintaining a comfortable ambient temperature and avoiding drafts helps cats that may have difficulty regulating body temperature due to illness.

Maintaining quality of life involves attention to physical comfort and emotional wellbeing. Gentle grooming helps cats that are not maintaining their coats well due to illness, and the contact can be comforting. Offering small, frequent meals of highly palatable foods encourages eating, and warming food slightly may increase its appeal. Quiet companionship, including simply sitting near the cat or gentle petting as tolerated, provides emotional comfort. Activities the cat still enjoys, such as watching outdoor activity from a window or receiving gentle attention, should continue as much as possible. Quality of life assessments should consider whether the cat still experiences more good moments than difficult ones.

Ongoing monitoring and communication with the veterinary team are essential components of managing pancreatic carcinoma. Regular veterinary check-ups, whether in clinic or through telemedicine consultations, allow assessment of disease status and adjustment of medications as needed. Owners should watch for signs of disease progression, including worsening appetite, increasing vomiting, new jaundice or worsening of existing jaundice, and declining activity levels. Pain indicators such as hiding, reluctance to move, changes in breathing, or vocalization warrant prompt attention. Clear communication with the veterinarian about observations and concerns ensures that the care plan remains appropriate as the disease progresses.

Caring for a cat with terminal cancer takes an emotional toll on caregivers, and attention to self-care is important. Accepting that cure is not possible while focusing on quality time together can help families cope with this difficult situation. Support from friends, family, veterinary social workers, or pet loss support groups can be valuable during this time. Financial planning for ongoing care costs and potential end-of-life decisions reduces stress related to these practical concerns. Making decisions about when the cat's quality of life has declined to the point that euthanasia becomes the kindest option is difficult, and the veterinary team can provide guidance and support in making this determination. Focusing on providing comfort and love during whatever time remains creates meaningful final experiences together.

Pancreatic carcinoma does not show a clear breed predisposition in cats, with the disease affecting all breeds and mixed-breed cats with similar frequency. The rarity of this cancer type has limited opportunities for large-scale epidemiological studies that might reveal subtle breed associations. Available evidence suggests that any cat, regardless of breed, can potentially develop pancreatic carcinoma, with age being a more significant risk factor than genetic background. Both purebred and domestic shorthair and longhair cats are represented in reported cases, reflecting the general cat population distribution rather than specific breed susceptibility.

While specific breed predispositions are not documented, certain demographic factors are associated with increased risk. Age is the most significant factor, with the vast majority of pancreatic carcinoma cases occurring in senior cats over ten years of age. No consistent sex predilection has been identified, with both male and female cats affected. Body condition may play a role in some cancers, though specific associations with pancreatic carcinoma have not been established. Cats with a history of chronic pancreatitis might theoretically be at increased risk, though this relationship has not been conclusively demonstrated.

Screening recommendations for pancreatic carcinoma are not well established due to the rarity of the condition and lack of effective early detection methods. General health screening for senior cats, including regular physical examinations and blood work, may detect abnormalities that prompt further investigation. Abdominal ultrasound can identify pancreatic masses but is not routinely performed as a screening test in asymptomatic cats. For cats presenting with nonspecific symptoms such as weight loss, decreased appetite, or vomiting, particularly in senior cats, pancreatic disease should be considered in the differential diagnosis. Owners of senior cats should be aware of symptoms that warrant veterinary attention and seek evaluation promptly when concerns arise, as early detection offers the best opportunity for treatment when it is possible.

Several conditions commonly co-occur with or are related to pancreatic carcinoma in cats, sharing anatomical location or clinical presentations. Pancreatitis, inflammation of the pancreas, is much more common than pancreatic cancer and can cause similar symptoms including vomiting, decreased appetite, and abdominal pain. Chronic pancreatitis may theoretically predispose to cancer development, though this relationship is not proven in cats. Diabetes mellitus can develop secondary to pancreatic carcinoma if the tumor destroys enough of the insulin-producing islet cells, and managing concurrent diabetes adds complexity to the care of affected cats. Exocrine pancreatic insufficiency, where the pancreas fails to produce adequate digestive enzymes, can result from extensive pancreatic disease.

Numerous conditions present with symptoms similar to pancreatic carcinoma and must be differentiated during diagnosis. Inflammatory bowel disease causes chronic gastrointestinal symptoms including vomiting, diarrhea, weight loss, and decreased appetite that overlap significantly with pancreatic carcinoma presentation. Intestinal lymphoma, a common feline cancer, causes similar nonspecific gastrointestinal symptoms. Hepatic lipidosis and other liver diseases can cause jaundice and anorexia similar to pancreatic tumors affecting the bile duct. Chronic kidney disease causes weight loss and decreased appetite in senior cats. Accurate differentiation requires thorough diagnostic evaluation, as treatment approaches differ substantially among these conditions.

Potential complications of pancreatic carcinoma include local and distant effects of the primary tumor. Bile duct obstruction occurs when the tumor compresses or invades the common bile duct, causing jaundice and potentially liver damage if unrelieved. Metastatic spread commonly affects the liver, regional lymph nodes, and lungs, with each metastatic site potentially causing additional symptoms. Diabetes mellitus develops if sufficient pancreatic tissue is destroyed. Cachexia, the severe weight loss and muscle wasting associated with cancer, significantly impacts quality of life. Gastrointestinal obstruction can occur if tumor growth impinges on the stomach or intestines. Preventing complications is difficult given the aggressive nature of this cancer, but prompt veterinary attention when new symptoms develop allows for supportive care to address complications as they arise.